Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

NextPlat Unveils AI-Powered ClearMetrX 4.0 To Boost Healthcare Efficiency

Author: Benzinga Newsdesk | September 23, 2025 08:07am

Enhanced Software Suite to Feature AI-Assisted Analytics and Insights Designed to Support Greater Efficiency in Healthcare Operations While Driving Improved Patient Adherence and Outcomes

HALLANDALE BEACH, Fla., Sept. 23, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ:NXPL) (NASDAQ:NXPLW) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide, today announced that its ClearMetrx subsidiary has commenced late-stage development of ClearMetrX 4.0, the next generation of its proprietary healthcare data analytics and reporting software featuring a full range of artificial intelligence (AI)-enhanced capabilities. ClearMetrX 4.0 is expected to be rolled out internally in Q4, 2025. The Company intends to commercialize the software for new and existing customer deployments in the first half of 2026.

ClearMetrX is a cloud-based, end-to-end reporting platform that streamlines data analytics for physicians, management services organizations (MSOs), 340B entities, and pharmacies, and is actively used across the Company's pharmacies and client network. ClearMetrX 4.0 will integrate an array of AI-powered enhancements into the software, designed to increase its value as a comprehensive decision-support system, enabling a more streamlined way to collect, analyze and operationalize organizational healthcare data. According to Grandview Research, the global AI in healthcare market size was estimated at USD 26.57 billion in 2024 and is projected to reach USD 187.69 billion by 2030, growing at a CAGR of 38.62% from 2025 to 2030. A key factor driving market growth is the increasing demand in the healthcare sector for enhanced efficiency, accuracy, and better patient outcomes.

Birute Norkute, Vice President of Healthcare Operations at NextPlat, said, "Since its introduction, ClearMetrX has demonstrated its capabilities to positively impact not only the business of healthcare for us and a growing list of customers, but importantly, support better outcomes through improved patient adherence. With ClearMetrX 4.0, we are honoring our commitment to harness the power of technology such as AI to further improve the efficiency and effectiveness of healthcare to the benefit of all stakeholders."

Highlighted features of ClearMetrX 4.0 include:

  • Revenue Forecasting: Utilizing AI/ML models to predict revenue, prescription volumes, and patient demand with accuracy.
  • Predictive Inventory Management: Intelligent AI forecasting to optimize stock levels and reduce shortages or waste.
  • Anomaly & Exception Detection: Real-time AI tools to spot abnormal prescribing, dispensing, or claims patterns.
  • Audit Assistance, Analytics & Reporting: AI-powered dashboards that automate evidence gathering, compliance reporting, and deliver actionable analytics.
  • Fraud Detection: Advanced AI analytics to identify suspicious billing or dispensing activity.
  • What-If Simulations: AI-driven scenario models to evaluate financial and compliance outcomes.

Posted In: NXPL NXPLW

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist